ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
US Tech 100
21,199.66
1.36%
Dow Jones
43,297.03
0.91%
Brent Oil
73.285
0.80%
Bitcoin
98,179.66
3.68%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Oruka Therapeutics Inc (ORKA) Quote

Oruka Therapeutics Inc

Oruka Therapeutics Inc (ORKA)

NASDAQ
21.13
0.13
( 0.62% )
Updated: 13:42:14
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
21.13
Bid
20.50
Ask
21.13
Volume
240,572
20.50 Day's Range 21.67
18.20 52 Week Range 31.13
Previous Close
21.00
Open
20.86
Last Trade
5325
@
21.13
Last Trade Time
13:00:00
Average Volume (3m)
222,629
Financial Volume
$ 5,058,237
VWAP
21.0259

Ask ADVFN Intelligence (AI)

ORKA Latest News

More News

Form 8-K - Current report

December 19 2024
Edgar (US Regulatory)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Pharmacokinetic and safety data from healthy volunteers anticipated in the second half of 2025 On track to initiate a proof-of-concept study in psoriasis in the second half of 2025, with initial...

December 19 2024
GlobeNewswire Inc.

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

MENLO PARK, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

December 18 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

November 27 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

November 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 21 2024
Edgar (US Regulatory)

Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare Conference

MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the...

November 19 2024
GlobeNewswire Inc.

Form 8-K - Current report

November 18 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.98-8.567719601923.1123.5719.837593723420.86694084CS
41.769.0862157976319.3725.6518.239211221.35297156CS
12-3.63-14.660743134124.7631.1318.222262923.1048301CS
26-4.37-17.13725490225.531.1318.218167323.24747078CS
52-4.37-17.13725490225.531.1318.218167323.24747078CS
156-4.37-17.13725490225.531.1318.218167323.24747078CS
260-4.37-17.13725490225.531.1318.218167323.24747078CS

ORKA - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics share price?
The current share price of Oruka Therapeutics is $ 21.13
What is the 1 year trading range for Oruka Therapeutics share price?
Oruka Therapeutics has traded in the range of $ 18.20 to $ 31.13 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
$ 7.10
(310.40%)
58.36M
HOURHour Loop Inc
$ 4.40
(207.69%)
96.83M
GTIGraphjet Technology
$ 0.61
(168.72%)
263.81M
CREVCarbon Revolution Public Ltd
$ 9.16
(135.48%)
26.83M
AVGRAvinger Inc
$ 1.45
(125.72%)
107M
SLGLSol Gel Technologies Ltd
$ 0.9798
(-40.62%)
3.02M
DRCTDirect Digital Holdings Inc
$ 3.71
(-32.55%)
23.66M
CHEKCheck Cap Ltd
$ 1.55
(-31.11%)
3.46M
SYTASiyata Mobile Inc
$ 0.5178
(-30.83%)
2.53M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
$ 15.47
(-30.38%)
147.45k
SVMHSRIVARU Holding Ltd
$ 0.0338
(20.71%)
277.81M
GTIGraphjet Technology
$ 0.61
(168.72%)
263.81M
LITMSnow Lake Resources Ltd
$ 0.5849
(52.84%)
179.63M
LCIDLucid Group Inc
$ 3.20
(3.23%)
108.07M
RGTIRigetti Computing Inc
$ 11.35
(3.56%)
107.66M

Discussion

View Full Feed
excel excel 3 minutes ago
They looked like totally different team last week.

Played well both sides.

I rarely do this ...........

I pick with my heart so had to pick wilson this week to pull it off for Pit after last weeks mistakes he made.

Hope past history of how
martyDg martyDg 3 minutes ago
I suspect 2025 will truly be a new world for us who invest in NWBO

You should use the word "hope" instead of suspect cuz we can only hope that they MAY get approval or rejection next year. There's no guarantee cuz MHRA and NWBO have something in common that's being SLOWPOKE.
NWBO
Lurker3 Lurker3 3 minutes ago
Nothing is solid with lwlg its hanging from loose sand
LWLG
ShawnP123 ShawnP123 3 minutes ago
I find it very interesting traders keeping this under 140.
NVDA
hopeok hopeok 3 minutes ago
Merry Christmas.
WKSP
Natural Trader Natural Trader 3 minutes ago
Merry Christmas to all
my3sons87 my3sons87 4 minutes ago
IDCC 2024 full year revenue projection in last sentence. I said about $800 million in my prior post. IDCC says $860 million.

IDCC
georgie18 georgie18 4 minutes ago
Not in...🥳saw the move but too many others that I am building positions with...Enjoy...
TIVC
havnagoodtime havnagoodtime 4 minutes ago
Hilarious. Yeah, I'm shorting 2Mil shares. All I had to do was satisfy my broker's requirement of putting up $2.50 per share -- a total of $5,000,000. Easy Peasy. Why isn't everyone doing that? ;-)
HMBL
Bud-Wiser Bud-Wiser 4 minutes ago
Thank you Merry Christmas 🎁 and Happy Holidays to everyone here !! Maybe we get a miracle RUN here in 2025 
CGAC
Big Al T Big Al T 5 minutes ago
AMAZING

"Just think, right now, RadioGel is killing cancer cells in a human being.

LET THAT SINK IN!
RDGL
ChannelTrader ChannelTrader 5 minutes ago
Yes, definitely.
Thank you, CH... excellent movie...love it.
That one and Its a Wonderful Life James Stewart

A Merry Christmas and a classic for all to watch

A Christmas Carol. "Scrooge" Movie 1951
gitreal gitreal 6 minutes ago
Nice video but found a more realistic picture of Chris Torres and his friends in Imagination Land:

https://investorshub.advfn.com/uimage/uploads/2021/5/11/qjsrkImagination_Land.jpg
AABB
BasedOnFeels BasedOnFeels 6 minutes ago
Wondering why $60k+ sitting on 6s aren't being bid whacked by the big bad front loaders.
And the $100k on 5's
And the $150k on 4's etc etc
And why 3.4b shares are being held tight in the last 2 weeks, especially when there has been no dilution in 3-4 years.
Why are new i
GRLT
fuagf fuagf 8 minutes ago
Surely is basically for the off-road, rough track vehicles, whatever
they are called. I've never been into cars, like so many guys are.
AtlasQ AtlasQ 8 minutes ago
Merry Christmas everyone 
RDGL
tw0122 tw0122 10 minutes ago
I suppose .16 to .30 made some rich 
LICN
pappythom1 pappythom1 10 minutes ago
happy holidays,Mr. Grinch
QSEP
otterman otterman 11 minutes ago
$TOVX +30% today.

Next year gonna be fun.
TOVX
poster44ny poster44ny 11 minutes ago
Robust Presales for HHSE Book on Trump Temporarily Shuts Down Amazon Orders
News Provided By
Hannover House / MyFlix
December 24, 2024, 18:01 GMT
Share This Article


Presale consumer demand was so strong for this new Trump book, that Amazon has
HHSE
tw0122 tw0122 11 minutes ago
Vagus nerve made it to .50s premarket  at .30s now
TIVC

Your Recent History

NASDAQ
ORKA
Oruka Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads